EUVIMEDEUVIMED entdecken
Übersichtsarbeit

TREM2 as a Therapeutic Target in Atherosclerosis

Siting Xu, Bo Yang, Wenhua Yu, Yun Gao, Honghua Cai, Zhongqun Wang

Cell Biology International · 2025

DOI: 10.1002/cbin.12279 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology International, 2025. Verfasst von Siting Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China. Hauptthemen laut MEDLINE: Atherosclerosis, Receptors, Immunologic, Membrane Glycoproteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: The research was supported by National Natural Science Foundation of China (82370457)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is driven by the expansion of cholesterol‐loaded foamy macrophages in the arterial intima. Single‐cell RNA sequencing has recently revealed the transcriptional landscape of macrophages in these atherosclerotic plaques and uncovered a population of foamy cell‐like myeloid cells expressing triggering receptor expressed on myeloid cells‐2 (TREM2)—TREM2 hi macrophages. Fundamental research has brought essential insight into the significance of TREM2 for foam macrophage survival and atherosclerosis progression, making TREM2 as a therapeutic target in atherosclerosis possible. This review retraces TREM2's winding route from pure knowledge to therapeutic interventions, as well as the potential feasibility of its clinical application for atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisReceptors, ImmunologicMembrane GlycoproteinsHumansAnimalsFoam CellsMacrophagesPlaque, Atherosclerotic

Stichwörter der Autor:innen

TREM2atherosclerosismacrophage

Substanzen

Receptors, ImmunologicMembrane GlycoproteinsTREM2 protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Department of Pathology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Department of Burn and Plastic Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China.

Förderung

  • The research was supported by National Natural Science Foundation of China (82370457).

Zitieren

APA

Xu, S., Yang, B., Yu, W., Gao, Y., Cai, H., & Wang, Z. (2025). TREM2 as a Therapeutic Target in Atherosclerosis. Cell Biology International. https://doi.org/10.1002/cbin.12279

Vancouver

Xu S, Yang B, Yu W, Gao Y, Cai H, Wang Z. TREM2 as a Therapeutic Target in Atherosclerosis. Cell Biology International. 2025. doi:10.1002/cbin.12279

BibTeX
@article{Xu2025,
  author = {Xu, Siting and Yang, Bo and Yu, Wenhua and Gao, Yun and Cai, Honghua and Wang, Zhongqun},
  title = {TREM2 as a Therapeutic Target in Atherosclerosis},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.12279}
}
Kostenlos starten →